Exhibit 15
Board of Directors
Xechem International, Inc.
We have reviewed the accompanying consolidated balance sheet of Xechem
International, Inc. and its subsidiaries as of September 30, 2000, and the
related consolidated statements of operations, stockholders' equity and cash
flows for the three-month and nine-month periods then ended. These consolidated
financial statements are the responsibility of the Company's management.
We conducted our review in accordance with standards established by
the American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical procedures to
financial data and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.
Based on our review, we are not aware of any material modifications
that should be made to the accompanying consolidated financial statements for
them to be in conformity with generally accepted accounting principles.
The accompanying consolidated financial statements have been prepared
assuming Xechem International, Inc. and its subsidiaries will continue as a
going concern. As discussed in Note 2 to the consolidated financial statements
appearing in Form 10-KSB for the year ended December 31,1999, the Company has
suffered recurring losses from operations and has a net capital deficiency that
raise substantial doubt about its ability to continue as a going concern.
Management's plans in regard to these matters are also described in Note 2. The
consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
/s/ Wiss & Company
----------------------------------
Wiss & Company, LLP
Livingston, New Jersey
November 03, 2000
